Re: Long-Term Outcomes of Active Surveillance for Prostate Cancer: The Memorial Sloan Kettering Cancer Center Experience
- 1 February 2021
- journal article
- letter
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Urology
- Vol. 205 (2), 340-341
- https://doi.org/10.1097/ju.0000000000001420
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Structured Population-based Prostate-specific Antigen Screening for Prostate Cancer: The European Association of Urology Position in 2019European Urology, 2019
- Prebiopsy Biparametric Magnetic Resonance Imaging Combined with Prostate-specific Antigen Density in Detecting and Ruling out Gleason 7–10 Prostate Cancer in Biopsy-naïve MenEuropean Urology Oncology, 2018
- Prediction of High-grade Prostate Cancer Following Multiparametric Magnetic Resonance Imaging: Improving the Rotterdam European Randomized Study of Screening for Prostate Cancer Risk CalculatorsEuropean Urology, 2018
- Prostate Cancer Risk Assessment in Biopsy-naïve Patients: The Rotterdam Prostate Cancer Risk Calculator in Multiparametric Magnetic Resonance Imaging-Transrectal Ultrasound (TRUS) Fusion Biopsy and Systematic TRUS BiopsyEuropean Urology Oncology, 2018
- MRI-Targeted or Standard Biopsy for Prostate-Cancer DiagnosisThe New England Journal of Medicine, 2018